Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicaid Would Pay ASP+6% To Pharmacies Under White House Bill

Executive Summary

The Centers for Medicare & Medicaid Services is forging ahead with its proposal to set pharmacy reimbursement levels under Medicaid at average sales price plus 6% for drugs, despite opposition from industry groups and state governors

You may also be interested in...



AMP Model For Upper Limit Program Could Save Medicaid Over $100 Mil. – IG

The HHS Office of Inspector General renewed its call for reform of the Medicaid federal upper limit list inclusion criteria in a recent report

AMP Model For Upper Limit Program Could Save Medicaid Over $100 Mil. – IG

The HHS Office of Inspector General renewed its call for reform of the Medicaid federal upper limit list inclusion criteria in a recent report

Wholesaler Fees Could Wither Under Medicaid AMP System, Cardinal Says

Medicaid drug reimbursement based on average manufacturer price or average sales price could create "barriers" to wholesalers receiving the payments they typically are paid by manufacturers, Cardinal VP-Professional & Government Relations Connie Woodburn told the National Association of Chain Drug Stores' Pharmacy & Technology Conference Aug. 30 in San Diego

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel